OPTIMER PHARMACEUTICALS INC Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows, 4 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-04-09: Reporting owner Chang Michael N; Form 4; Security Common stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2011-01-26: Reporting owner Gorbach MD Sherwood; Form 4; Security Common stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-12-03: Reporting owner Hartman Kurt M; Form 3; Security No Securities Beneficially Owned; Transaction Holding.
- 2010-01-04: Reporting owner Che Tessie M; Form 4; Security Common Stock; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-04-09 | Chang Michael N Director | 4 | Common stock Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −18,750 0 owned after | $12.34 exercise price | 2013-04-11 | |
| 2011-01-26 | Gorbach MD Sherwood Officer (SVP and Chief Medical Officer) | 4 | Common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +40,000 40,000 owned after | $11.41 exercise price | 2011-01-27 | |
| 2010-12-03 holding as of filing | Hartman Kurt M Officer (General Counsel and Access) | 3 | No Securities Beneficially Owned Non-derivative · Direct | Holding | 0 owned after | no price filed | 2010-12-03 | |
| 2010-01-04 | Che Tessie M Officer (COO and SVP) | 4 | Common Stock Derivative · Indirect · (m) | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −46,153 0 owned after | $1.08 exercise price | 2010-01-05 |